Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-914-9 | CAS number: 16881-77-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 Feb - 26 Apr 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- Jul 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
Test material
- Reference substance name:
- Dimethoxymethylsilane
- EC Number:
- 240-914-9
- EC Name:
- Dimethoxymethylsilane
- Cas Number:
- 16881-77-9
- Molecular formula:
- C3H10O2Si
- IUPAC Name:
- Dimethoxy(methyl)silane
- Test material form:
- liquid
Constituent 1
Method
- Target gene:
- TK locus
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: L5178Y/TK+/- -3.7.2C mouse lymphoma cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: L5178Y/TK+/- -3.7.2C mouse lymphoma cells (American Type Culture Collection, Manassas, USA).
- Suitability of cells: recommended test system in OECD TG 490.
For cell lines:
- Absence of Mycoplasma contamination: yes, the stock cultures were checked for mycoplasma contamination.
- Methods for maintenance in cell culture: stock cultures of the cells were stored in the ultra-low freezer set to maintain -150°C. Cell density was kept below 1E+06 cells/mL.
- Periodically ‘cleansed’ of spontaneous mutants: yes, prior to testing, the mouse lymphoma cells were grown for 1 day in growth medium containing 1E-04 M hypoxanthine, 2E-07 M aminopterine and 1.6E-05 M thymidine (HAT-medium) to reduce the amount of spontaneous mutants, followed by a recovery period of 2 days in growth medium containing hypoxanthine and thymidine only. After this period cells were returned to growth medium for at least 1 day before starting the experiment.
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature, if applicable:
Basic medium: RPMI 1640 Hepes buffered medium containing penicillin/streptomycin (50 U/mL and 50 μg/mL, respectively), 1 mM sodium pyruvate and 2 mM L-glutamin.
Growth medium: basic medium, supplemented with 10% (v/v) heat-inactivated horse serum.
Exposure medium: cells were exposed to the test material in basic medium supplemented with 5% to 10% (v/v) heat-inactivated horse serum.
Selective medium: selective medium consisted of basic medium supplemented with 20% (v/v) heat-inactivated horse serum and 5 µg/mL trifluorothymidine (TFT).
Non-selective medium: non-selective medium consisted of basic medium supplemented with 20% (v/v) heat-inactivated horse serum.
All incubations were carried out in a humid atmosphere (80 - 100%, actual range 37.7 – 103.0%) containing 5.0 ± 0.5% CO2 in air in the dark at 37.0 ± 1.0°C (actual range 34.2 – 38.9°C).
- Cytokinesis block (if used):
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: Trinova Biochem GmbH, Giessen, Germany (S9 homogenate prepared from male Sprague Dawley rats that had been dosed orally with a suspension of phenobarbital (80 mg/kg body weight) and ß-naphthoflavone (100 mg/kg body weight))
- method of preparation of S9 mix: S9-mix was prepared immediately before use and kept refrigerated. S9-mix components contained per mL physiological saline: 1.63 mg MgCl2.6H2O; 2.46 mg KCl; 1.7 mg glucose-6-phosphate; 3.4 mg NADP; 4 µmol HEPES. The above solution was filter (0.22 µm)-sterilized. To 0.5 mL S9-mix components 0.5 mL S9-fraction was added (50% (v/v) S9-fraction) to complete the S9-mix. The concentration of the S9-fraction in the exposure medium was 4% (v/v). - Test concentrations with justification for top dose:
- Experiment 1: 7.8, 16, 31, 63, 125, 250, 500 and 1051.9 µg/mL (3 hour exposure with and without S9)
Experiment 2: 16, 31, 63, 125, 250, 500, 750 and 1051.9 µg/mL (24 hour exposure without S9)
Concentrations for the main experiments were selected based on the results of a dose range finding study. The highest tested concentration was 1051.9 µg/mL exposure medium (0.01 M), as recommended in OECD TG 490. At this concentration no significant cytotoxicity was observed, therefore, 1051.9 µg/mL was selected as the highest concentration for the main experiments. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: a solubility test was performed based on visual assessment. The test item formed a clear colorless solution in DMSO.
- Justification for percentage of solvent in the final culture medium: the final concentration of the solvent in the culture medium was 1% (v/v), therefore, not exceeding 1% for an organic solvent, as per the OECD guideline requirement.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: single cultures for the test item and positive controls; duplicate cultures for the solvent control
- Number of independent experiments: 2 (excluding dose range finder)
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 8E+06 cells (1E+06 cells/mL for 3 hour treatment) or 6E+06 cells (1.25E+05 cells/mL for 24 hour treatment)
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment:
Experiment 1: 3 hours (with and without S9)
Experiment 2: 24 hours (without S9)
- Harvest time after the end of treatment: immediately after treatment
FOR GENE MUTATION:
- Expression time: 2 days
- Selection time: 11 or 12 days
- Fixation time: 13 to 14 days
- Method used: microwell plates for the mouse lymphoma assay
- If a selective agent is used: 5 µg/mL trifluorothymidine (TFT)
- Number of cells seeded and method to enumerate numbers of viable and mutants cells: for determination of the cloning efficiency (CEday2) the cell suspensions were diluted and seeded in wells of a 96-well dish. One cell was added per well (2 x 96-well microtiter plates/concentration) in non-selective medium.
For determination of the mutant frequency (MF) a total number of 9.6E+05 cells per concentration were plated in five 96-well microtiter plates, each well containing 2000 cells in selective medium (TFT-selection), with the exception of the positive control groups (MMS and CP) where a total number of 9.6E+05 cells/concentration were plated in ten 96-well microtiter plates, each well containing 1000 cells in selective medium (TFT-selection). The microtiter plates for CEday2 and MF were incubated for 11 or 12 days.
After the incubation period, the plates for the TFT-selection were stained for 1.5-2 hours, by adding 0.5 mg/mL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to each well. The plates for the CE day2 and MF were scored with the naked eye or with the microscope.
- Criteria for small (slow growing) and large (fast growing) colonies: the small colonies are morphologically dense colonies with a sharp contour and with a diameter less than a quarter of a well. The large colonies are morphologically less dense colonies with a hazy contour and with a diameter larger than a quarter of a well. A well containing more than one small colony is classified as one small colony. A well containing more than one large colony is classified as one large colony. A well containing one small and one large colony is classified as one large colony.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: relative suspension growth (RSG); relative total growth (RTG); relative cloning efficiency (RCE)
METHODS FOR MEASUREMENTS OF GENOTOXICIY
- Method: mutant frequency (MF) - Evaluation criteria:
- In addition to the criteria stated below, any increase of the mutant frequency was evaluated for its biological relevance including comparison of the results with the historical control data range.
The global evaluation factor (GEF) has been defined by the IWGT as the mean of the negative/solvent MF distribution plus one standard deviation. For the micro well version of the assay the GEF is 126.
A test material is considered positive (mutagenic) in the mutation assay if it induces a MF of more than MF (controls) + 126 in a dose-dependent manner. An observed increase should be biologically relevant and will be compared with the historical control data range.
A test material is considered equivocal (questionable) in the mutation assay if no clear conclusion for positive or negative result can be made after an additional confirmation study.
A test material is considered negative (not mutagenic) in the mutation assay if none of the tested concentrations reaches a mutant frequency of MF (controls) + 126.
Results and discussion
Test results
- Species / strain:
- mammalian cell line, other: L5178Y/TK+/- -3.7.2C mouse lymphoma cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- The test item was tested up to the maximum recommended concentration of 1051.9 µg/mL (0.01 M) in Experiments 1 and 2. In Experiment 1, the test item precipitated at the 1051.9 µg/mL with and without S9-mix. In Experiment 2, no precipitation was observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- DOSE RANGE-FINDING STUDY:
In the dose-range finding test, L5178Y mouse lymphoma cells were treated with a test material concentration range of 63 to 1051.9 µg/mL in the absence of S9-mix with 3 and 24 hour treatment periods and in the presence of S9-mix with a 3 hour treatment period.
The highest concentration which did not precipitate directly in the exposure medium was 1051.9 μg/mL. The pH and osmolarity at a concentration of 1051.9 μg/mL were 7.2 and 0.480 Osm/kg, respectively (compared to 7.2 and 0.474 Osm/kg in the solvent control).
Table 1 (attached background material) shows the cell counts of the cultures from the 3 hours of treatment with various concentrations of the test material after 24 and 48 hours of subculture, the calculated suspension growth and the relative suspension growth.
Both in the absence and presence of S9-mix, no toxicity in the relative suspension growth was observed up to and including the highest test material concentration of 1051.9 μg/mL compared to the solvent control.
Table 2 (attached background material) shows the cell counts of the cultures after 24 hours of treatment with various concentrations of the test material and after 24 hours of subculture and the calculated suspension growth and the relative suspension growth.
No toxicity in the relative suspension growth was observed up to test material concentrations of 1051.9 μg/mL compared to the solvent control.
STUDY RESULTS
Summary tables presented in the field "any other information on results incl. tables" show the percentages of cell survival and the mutation frequencies for various concentrations of the test material. Individual colony counts of cloning and selective plates and cell counts during sub-culturing are listed in Table 7 to Table 11 (attached background material).
After 3 hours, the test material precipitated in the exposure medium at a concentration of 1051.9 µg/mL with and without metabolic activation. After 24 hours, no test item precipitation was observed.
Evaluation of toxicity:
No significant toxicity was observed in Experiments 1 and 2, therefore, the highest 8 dose levels were evaluated for mutant frequency.
Evaluation of the mutagenicity:
No biologically relevant increase in the mutant frequency at the TK locus was observed in either experiment (Experiment 1, 3 hour treatment with and without S9; Experiment 2, 24 hour treatment without S9). For both experiments, the numbers of small and large colonies in the test material treated cultures were comparable to the numbers of small and large colonies of the solvent controls.
Acceptability Criteria:
- The mutant frequency found in the solvent control cultures was within the acceptability criteria of this assay and within the 95% control limits of the distribution of the historical negative control database (See Table 5, attached background material).
- Positive control chemicals, methyl methanesulfonate and cyclophosphamide, both produced significant increases in the mutant frequency. In addition, the mutant frequency found in the positive control cultures was within the 95% control limits of the distribution of the historical positive control database (see Table 6, attached background material). It was therefore concluded that the test conditions were adequate and that the metabolic activation system (S9-mix) functioned properly.
- The suspension growth over the two-day expression period for cultures treated with DMSO was between 9 and 20 (3 hour treatment) and 85 and 91 (24 hour treatment)
HISTORICAL CONTROL DATA
- see attached background information
Any other information on results incl. tables
Experiment 1 - 3 h exposure - Without Metabolic Activation
Concentration | Relative suspension growth [%] | CEday2 [%] | Relative cloning efficiency [%] | Relative Total Growth [%] | Mutants per 1E+06 surviving cells | Small colony | Large colony |
0 (DMSO) | 100 | 116 | 100 | 100 | 65 | 31 | 32 |
0 (DMSO) | 95 | 73 | 27 | 43 | |||
7.8 | 79 | 110 | 104 | 83 | 63 | 30 | 30 |
16 | 103 | 108 | 102 | 105 | 76 | 39 | 34 |
31 | 112 | 97 | 91 | 102 | 69 | 22 | 45 |
63 | 100 | 101 | 95 | 95 | 66 | 31 | 33 |
125 | 108 | 83 | 78 | 85 | 62 | 24 | 36 |
250 | 122 | 98 | 93 | 113 | 62 | 26 | 34 |
500 | 112 | 105 | 99 | 111 | 52 | 18 | 33 |
1051.9# | 103 | 93 | 88 | 90 | 66 | 18 | 46 |
MMS, 15 | 79 | 62 | 59 | 46 | 749 | 249 | 418 |
MMS = methylmethanesulfonate
# = test item precipitation in exposure medium
Experiment 1 - 3 h exposure - With Metabolic Activation
Concentration | Relative suspension growth [%] | CEday2 [%] | Relative cloning efficiency [%] | Relative Total Growth [%] | Mutants per 1E+06 surviving cells | Small colony | Large colony |
0 (DMSO) | 100 | 104 | 100 | 100 | 95 | 34 | 56 |
0 (DMSO) | 105 | 102 | 26 | 71 | |||
7.8 | 114 | 101 | 97 | 110 | 70 | 34 | 33 |
16 | 103 | 110 | 105 | 108 | 92 | 39 | 49 |
31 | 92 | 94 | 90 | 83 | 109 | 18 | 88 |
63 | 131 | 91 | 87 | 114 | 135 | 38 | 90 |
125 | 57 | 111 | 107 | 61 | 94 | 22 | 69 |
250 | 143 | 83 | 79 | 113 | 97 | 31 | 62 |
500 | 96 | 99 | 95 | 91 | 90 | 30 | 56 |
1051.9# | 127 | 101 | 97 | 123 | 97 | 42 | 50 |
CP, 5 | 126 | 81 | 78 | 98 | 670 | 329 | 252 |
CP = cyclophosphamide
# = test item precipitation in exposure medium
Experiment 2 - 24 h Exposure - Without Metabolic Activation
Concentration | Relative suspension growth [%] | CEday2 [%] | Relative cloning efficiency [%] | Relative Total Growth [%] | Mutants per 1E+06 surviving cells | Small colony | Large colony |
0 (DMSO) | 100 | 102 | 100 | 100 | 89 | 46 | 39 |
0 (DMSO) | 97 | 59 | 28 | 30 | |||
16 | 97 | 110 | 110 | 108 | 52 | 22 | 28 |
31 | 93 | 95 | 96 | 89 | 74 | 18 | 54 |
63 | 87 | 110 | 110 | 96 | 53 | 20 | 31 |
125 | 97 | 102 | 103 | 100 | 58 | 25 | 32 |
250 | 96 | 110 | 110 | 106 | 51 | 16 | 33 |
500 | 71 | 129 | 129 | 92 | 52 | 19 | 31 |
750 | 96 | 91 | 92 | 88 | 58 | 20 | 37 |
1051.9 | 81 | 115 | 115 | 93 | 72 | 35 | 34 |
MMS, 5 | 75 | 85 | 85 | 64 | 678 | 395 | 195 |
MMS = methylmethanesulfonate
Applicant's summary and conclusion
- Conclusions:
- Dimethoxy(methyl)silane has been tested for gene mutation in L5178Y/TK+/- -3.7.2C mouse lymphoma cells, in a study which was conducted according to OECD 490 and in compliance with GLP. No evidence of a biologically relevant increase in the mutant frequency was observed with or without metabolic activation in short- and long-term treatments. In conclusion, dimethoxy(methyl)silane was not mutagenic in the TK mutation test system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.